chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm was really sore; Hard for her to lift her arm up; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was really sore) and VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (Hard for her to lift her arm up) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was really sore) and VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (Hard for her to lift her arm up). At the time of the report, PAIN IN EXTREMITY (Arm was really sore) and VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (Hard for her to lift her arm up) outcome was unknown. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
patient developed hives/welts to the neck, breasts and abdomen. Had left facial swelling and lip swelling
Extreme fatigue within an hour of dose 2. Extremely  Sore, achy, tiered for 7-9 weeks. Once that started to resolve I had my first ever seizure. Have had 3 episodes of seizure to date. 04/2021 (grand mal/soiled the bed), 08/2021 (break through), 10/2021 (petite mal).
Fever, severe body aches, chills, headache, fatigue, swollen lymph nodes
Administer expired vaccine to patient, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient, after the manufacture date of expiration) in a 67-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Expiration Date for the lot 070H21A was reported as 07-Apr-2021 with total of 173 doses. The vial did not undergo any temperature excursions. Date the vial initially stored in the refrigerator was reported as unknown. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received contains non-significant information.
Multiple tender, swollen lymph nodes in left axilla initially, later moving also into left supraclavicular and left cervical lymph nodes. Started about 36 hours after vaccine administered and ended by 5-6 days after vaccine administered.
body aches; fever; glands were swollen; soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), PYREXIA (fever), LYMPHADENOPATHY (glands were swollen) and PAIN IN EXTREMITY (soreness in arm) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced MYALGIA (body aches), PYREXIA (fever), LYMPHADENOPATHY (glands were swollen) and PAIN IN EXTREMITY (soreness in arm). On 06-Mar-2021, PYREXIA (fever) had resolved. On 11-Mar-2021, MYALGIA (body aches), LYMPHADENOPATHY (glands were swollen) and PAIN IN EXTREMITY (soreness in arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was treated with Tylenol and Ibuprofen
Hot flashes; Inability to maintain body temp; Waking up drenched in sweat; Problems sleeping at night; Body aches; Headache; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot flashes), BODY TEMPERATURE FLUCTUATION (Inability to maintain body temp), HYPERHIDROSIS (Waking up drenched in sweat), INSOMNIA (Problems sleeping at night) and PAIN (Body aches) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MEDROXYPROGESTERONE ACETATE and NAPROXEN for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HOT FLUSH (Hot flashes), BODY TEMPERATURE FLUCTUATION (Inability to maintain body temp), HYPERHIDROSIS (Waking up drenched in sweat), INSOMNIA (Problems sleeping at night), PAIN (Body aches), HEADACHE (Headache), NAUSEA (Nausea) and FATIGUE (Fatigue). On 27-Feb-2021, PAIN (Body aches), HEADACHE (Headache), NAUSEA (Nausea) and FATIGUE (Fatigue) had resolved. At the time of the report, HOT FLUSH (Hot flashes), BODY TEMPERATURE FLUCTUATION (Inability to maintain body temp), HYPERHIDROSIS (Waking up drenched in sweat) and INSOMNIA (Problems sleeping at night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included Tylenol PM. Patient has taken Tylenol PM to help relieve symptoms, with no relief. HCP information gathered. Patient agreed for follow up with Safety.
Mild, continuous headaches, achey feeling in all muscles, especially the head; weakness, mile fever, difficult to keep awake more than 1 hour. Did not respond to Amoxyicillin.
After receiving the first dose of the COVID-19 vaccine (Pfizer), he had vomiting/dizziness x10 days
10 minutes after administration cough, diarrhea, decrease responsiveness, vomiting, itchy rash to ER - given BENADRYL in office prior to transport Alb 1.25 inject, O2.
Diagnosed with bladder cancer, METS to bone after 4 months of hematuria.
Patient had an allergic type reaction two days after receiving her Flu vaccine. She received the vaccine the morning of 10/14/2017 and was admitted to the Emergency Room the morning of 10/16/2017. She presented with itching at the injection site, severe redness and swelling, and it was hot to the touch. Patient did not report any symptoms the day of receiving the vaccine.
Pfizer-BioNTech COVID-19 Vaccine EUA COVID 19/Pfizer EL 9264  Nausea, tiredness, headache, muscle pain, flu Like symptoms, Ached all over for 14 hours......took Advil and symptoms subsided
I had horrible chills no fever.  I had a headache no as well.  My muscle ached, especially in my small joints.  The small joint aches were more awful than my other joint pain that I was experiencing.  I was taking Ibuprofen to help with the joint pain.  I saw my PCP, she prescribed Meloxicam for the joint pain.  This medicine helped the joint pain but when I stopped taking it the pain would return.  She also took an X-ray, which did not show any signs inflammation in my joints.  The pain went away gradually over time.
On 12/19/22, I came down with a cold. I had a fever of 102, body aches, coughing, fatigue, and sneezing. I went to the doctor but was not prescribed medication. I took TYLENOL but that was it. Finally, I started to feel better and then it came back about a week later. I have body aches, congestion, coughing, fatigue, and sneezing. I am having a hard time walking also. I went to the doctor, and they diagnosed Chronic Sinusitis. I was prescribed amoxicillin, benzonatate, and VENTOLIN. I am still dealing with these symptoms at this time.
No additional AEs reported; GARDASIL 9 was administered following a temperature excursion; This spontaneous report was received from an office manager referring to a 11-year-old female patient.  The patient's concurrent conditions, medical history, and concomitant therapies were not reported.  On 02-DEC-2022, the patient was vaccinated with one dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) pre-filled syringe injection, administered as prophylaxis (there were five possible lot # of the vaccine administered: lot #1775811, expiration date: 07-DEC-2023; lot #1775827, expiration date: 27-JUN-2024; lot #W009829, expiration date: 19-OCT-2024; lot #U032681, expiration date: 26-OCT-2023; and lot #1780876, expiration date: 09-NOV-2023; however, it was not specified which one was received by the patient) (strength, dose, route of administration, anatomical location, and vaccination scheme were not provided). It was reported that the vaccines suffered from three temperature excursions with a total of 25 minutes (on 09-SEP-2022 for 8 minutes; on 16-SEP-2022 for 5 minutes; and on 03-JAN-2023 for 12 minutes). The excursions were not noted until it was noticed that an employee mistakenly cleaned the data logger more than once a day (product storage error). There were no additional adverse events (AEs) reported in the patient (no adverse event).  This is one of several reports received from the same reporter.
pt recv vax OCT95 & devel inj site rxn,characterized by redness & induration;this is one of sever patients from this site who exp the above rxn;
I started having fever, chills, body ache, nausea, major headaches, congestion, diarrhea, and major fatigue.  I also loss tase and smell for about a week but even toady I am still no smelling and tasting everything.  Everything just tastes bitter. My son tested positive so I tested after Saturday and, I was positive. I figured I got it from him. I had a major headache and when I tested it was a faint line and then later that day I tested again, and the line of indication was bond and red. I called the office on the 9th but she wasn't in the office, yet she was transferring.  I finally talked to the doctor on the 11th,    My husband had COVID-19 pervious and was prescribed some medication and he couldn't take it, so this is the medication I took. It did help with in 24 hours I started improving as well as my inhaler. I did have some nausea it as well as the bad after taste. The mucus would get stuck in my throat and I use a vaporizer which I do feel like it did help. All these things together really helped me get better.
(Per mom) 10-28-10 child received TDAP- had  local reaction - redness, swelling at site - resolved. 11-3-10 noticed swelling, redness, fever, itching at site had child seen - Dx with Cellulitis - on BACTRIM & steroid.
Pt vax; exp dizziness, h/a, perspiration, & palpitations.
extremely tired; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events extremely tired/Fatigue.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) extremely tired.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), extremely tired was unknown.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-032814:case for 2nd sister MOD21-029201: US-MODERNATX, INC.-MOD-2021-032814:case for 2nd sister
AFTER THE VACCINATION, DURING THE OBSERVATION PERIOD, PATINET COMPLAINED TO HAVE STARTING TO EXPERIENCE ITCHING AT THE SITE OF ADMINISTRATION AND UNDER THE THROAT. AFTER COUPLE OF MINTUES HE MENTIONED TO HAVE ITCH ON CHEST AND OTHER PARTS OF THE BODY. PATIENT HAD NO SIGNS OR SYMPTOMS OF ANAPHYLAXIS  (i.e. TROUBLE BREATHING, TIGHNESS OF THROAT/LUNGS, HIVES OR RASH). I DIALLED 911 AND EMT ARRIVED WITHIN SHORT PERIOD OF TIME. PATIENT WAS TAKEN TO THE HOSPITAL (EMERGENCY) FOR FURTHER EVALUATION.
The patient passed out and later she was diagnosed with fibromyalgia; The patient passed out and later she was diagnosed with fibromyalgia; unspecified health issues; This spontaneous report was received from a consumer via a company representative, concerning a 13-years-old female patient. The patient's medical history, concurrent condition, concomitant medications, and drug allergies were not reported.   On an unknown date, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) for prophylaxis (route of administration, vaccine schedule, anatomical location, lot number, and expiration date were not reported).   In approximately 2005 (reported as 15-13 years ago), after the second dose of quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) for prophylaxis (route of administration, vaccine schedule, anatomical location, lot number, and expiration date were not reported), the patient passed out (loss of consciousness). Subsequently, the patient was diagnosed with fibromyalgia.   It was reported that she believed that fibromyalgia and other unspecified health issues (III-defined disorder) stem from quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) injection.  At the reporting time, it was unknown if the patient recovered from the events. The causal relationship between the loss of consciousness and vaccination with quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL) was not provided.  Upon internal review, the event loss of consciousness was determined to be medically significant.
Bilateral pulmonary embolism with saddle embolus. Presented with generalized weakness, shortness of breath,  generally feeling unwell
Fluvirin w/ Thimerosal given to OB pt. EDC = 11/09/2009. Pt NOT followed by OBGYN. Pt notified on 11/6/09. Denies any adverse effects. Pt NOT hospitalized after receiving H1N1 vaccine. 11/10/09 Medical records received. OB/GYN notes. 34 wks 2 days gestaion. Gestational diabetes, diet controlled. Sugars well controlled. Planned c-section. G3P2. Felt well at at 10/2/09 visit. (+) FHT and FM at 9/13/09 visit.11/16/2009 received Postpartum ck up note for 11/11/2009, mother and baby doing well, S/P C-section DC
This case was reported by a consumer via call center representative and described the occurrence of fever in a elderly female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced fever, headache, muscle pain, pain in arm and stomach discomfort. On an unknown date, the outcome of the fever, headache, muscle pain, pain in arm and stomach discomfort were unknown. It was unknown if the reporter considered the fever, headache, muscle pain, pain in arm and stomach discomfort to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient said she experienced all of the side effects listed plus a temperature of 101 and wanted to know whether it was normal. The patient experienced side effects like headache, muscle aches, fever of 101, whole arm pain and also mild stomach discomfort. Lab Comments: On unknown date, the body temperature was recorded.
Patient had an allergic reaction after receiving the Pfizer COVID-19 vaccine. Reaction included lip and tongue numbness and tingling and feeling that her throat was closing up. Patient was take to the ED for further evaluation
headache; body aches; Extreme pain/discomfort at the injection site; hazy feeling in brain; Extreme pain/discomfort at the injection site; This is a spontaneous report from a contactable consumer (Patient). A 58-year-old non pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date were not reported) via an unspecified route of administration, administered in left arm on 03Mar2021 at 15:00 (at the age of 58-year-old) at a single dose for COVID-19 immunisation at Pharmacy or Drug Store facility. Medical history included seizure disorder, seasonal allergies, depression, low back injury, DVT (Deep vein thrombosis) and obesity. Patient had no allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications (in two weeks) included Oxcarbazepine (TRILEPTAL), Sertraline, Acetylsalicylic acid (ASPIRIN LOW DOSE), Colecalciferol (VITAMIN D). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Mar2021 at 15:15, the patient experienced headache, body aches, extreme pain/discomfort at the injection site and hazy feeling in brain. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
STERILE WATER FOR INJECTION WAS MIXED IN AS A DILUENT. NO ADVERSE REACTION REPORTED BACK TO PHARMACY AT TIME OF THIS REPORT
The day after his vaccine he reports not feeling well: back pain, vomiting, fatigue, headache, muscle aches, rash (Mom checking to see if rash blanches - not home with him right now), nose bleed this morning.
Lightheaded, dizziness, sweaty, palpitations and nausea lasted for a few minutes.  At 08:05 am; Temp= 36.6 C, BP= 127/83, HR= 103, RR= 18, O2 Sats RA= 97%; at 0845: Temp= 36.6 C, BP= 116/82, HR= 106, RR= 18, O2 Sats RA= 98%
Dispersed petechiae and pruritis, treating with diphenhydramine started 09/17/2011.
Pt reported tongue felt different p/recvd flu vax 28OCT91 that evening pt devel a fever & ill feeling; following day pts tongue became raw & swollen w/welts & blisters; approx 2 wks later exp difficulty breathing & chest tightness;
Information has been received from a woman in a physician's office concerning a 5 year old white male with no past medical history who on 11/14/96 was vaccinated SQ with a 1st dose of varicella virus vaccine live (lot 619677/0834D). There was no illness at the time of vaccination. On 4/14/01, the pt broke out with chickenpox. He had 20+ lesions. It was reported that he acted ok, his diet was ok and he had a questionable fever. On an unknown date, the pt recovered.
Within 10 minutes of receiving the vaccine patient complained of dizziness and a slight headache.  Had patient sit down and drink something preferably water.  A few minutes later checked patient's blood pressure which was 160/98 mmHg, but patient was still complaining of feeling dizzy or like he was afraid he might fall if he stood up.   After eating lunch and drinking more fluids roughly 30 minutes after vaccine was administered  patient felt better and did not report any other or worsening symptoms. No medications were administered to patient to treat symptoms.
itchiness in her upper back and her scalp; nauseas; extremely tired; just a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness in her upper back and her scalp), NAUSEA (nauseas), FATIGUE (extremely tired) and PAIN (just a little sore) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL for Heart disease pulmonary.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form(s). On an unknown date, the patient experienced PRURITUS (itchiness in her upper back and her scalp), NAUSEA (nauseas), FATIGUE (extremely tired) and PAIN (just a little sore). At the time of the report, PRURITUS (itchiness in her upper back and her scalp) had resolved and NAUSEA (nauseas), FATIGUE (extremely tired) and PAIN (just a little sore) outcome was unknown.            Concomitants medication included 1/2 low doses of METOPROLOL SUCC 25 mg 1 table every day for heart.  No laboratory details were  provided.  Treatment medications included Benadryl and Zyrtec.   This case was linked to MOD-2021-046314 (Patient Link).
Since 5/24 I have been having some episodes of low blood pressure and high pulse rate (e.g. 81/49 BP, 129 pulse).  Experiencing at the same time palpitations, lightheadedness, fatigue, sleepiness. Frequency was average once a week but increased to nearly once per day in the last week.  I do not think this is related necessary to the vaccine. But as the question on the survey was if I have had any issues since, I am reporting it.
Tired, weakness, SOB on exertion (mild) left arm felt tingling & cold however felt warm to provider, no edema.
I developed dizziness and nausea and tittinus 3 days after vaccine, have visited my pcp and ENT have been given meclazine and lorazepan but nothing helps. It?s now been 8 weeks since my second shot on Feb.12 and I still can?t go to work.
This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX (Merck) which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the VARIVAX (Merck) information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received on 13-NOV-2014 from the registered nurse concerning a patient (age range reported as 6-12, units not reported) of unknown gender. On 21-OCT_2014, the patient was vaccinated with a dose of VARIVAX (Merck) which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Pt recvd 3 doses of Engerix-B vax 13JUL90, 16AUG90, 23JAN91 & it was determined that pt did not seroconvert;
I had extreme muscle pain from the injection site shooting down to my forearm into my hand. The pain went up my should around to my back and into my neck.  My arm was so painful that I could not move it and the next day the pain continues.  At around 6:30 pm I got very cold and piled on several blankets that did not warm me or help the shivering.  I had nausea for about 30 minutes starting at 7:30 pm. Two fingers became numb and normal feeling has not returned the following day. I have had many vaccines and never had pain like this.  The side effects of this vaccine are far worse than any I have experienced.  Even the anthrax vaccine was less painful.
Mom reports that pt received immunizations on 09/06/05. Then on 09/07/05 at 16:00 child began seizing.  Mom states from hospital, pt was flown to another hospital because the first hospital could not stop seizures. Per follow from 3/1/06 Child is seeing a neurologist at this time for follow up. Recieves med exemption for Dtap vaccines. Has not had any further seizures. Follow-up: Continues to see a Neurologist and is not taking further vaccines. Pt has delays in development before vaccine.
Loss of consciousness Neck pain that won't go away. With opiates see something. It does not allow head movements. With events of dizziness and increased pain.